Ubs Oconnor LLC Merus N.V. Transaction History

Ubs Oconnor LLC

$1.72 Billion
Q2 2024

A detailed history of Ubs Oconnor LLC transactions in Merus N.V. stock. As of the latest transaction made, Ubs Oconnor LLC holds 15,000 shares of MRUS stock, worth $707,850. This represents 0.05% of its overall portfolio holdings.

Number of Shares

15,000

Holding current value

$707,850

% of portfolio

0.05%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$39.81 - $60.2 $901,378 - $1.36 Million	-22,642 Reduced 71.56%	9,000 $532,000
Q1 2024 May 15, 2024	SELL	$28.03 - $51.82 $2.51 Million - $4.65 Million	-89,658 Reduced 73.91%	31,642 $1.42 Million
Q4 2023 Feb 14, 2024	SELL	$20.06 - $28.66 $617,968 - $882,899	-30,806 Reduced 20.25%	121,300 $3.34 Million
Q3 2023 Nov 14, 2023	BUY	$20.13 - $27.29 $100,650 - $136,450	5,000 Added 3.4%	152,106 $3.59 Million
Q2 2023 Aug 14, 2023	BUY	$18.33 - $27.18 $2.7 Million - $4 Million	147,106 New	147,106 $3.87 Billion
Q1 2023 May 15, 2023	BUY	$14.25 - $20.5 $723,615 - $1.04 Million	50,780 Added 78.97%	115,080 $2.12 Million
Q4 2022 Feb 14, 2023	SELL	$12.8 - $23.66 $164,044 - $303,226	-12,816 Reduced 16.62%	64,300 $0
Q3 2022 Nov 14, 2022	BUY	$18.64 - $28.93 $93,200 - $144,650	5,000 Added 6.93%	77,116 $1.55 Billion
Q2 2022 Aug 12, 2022	BUY	$13.98 - $29.25 $379,081 - $793,143	27,116 Added 60.26%	72,116 $1.63 Million
Q1 2022 May 16, 2022	BUY	$23.58 - $30.91 $1.06 Million - $1.39 Million	45,000 New	45,000 $1.19 Million

Others Institutions Holding MRUS

# of Institutions

188

Shares Held

59M

Call Options Held

345K

Put Options Held

222K

Rtw Investments, LP New York, NY

4.17M
Shares

$197 Million
4.12% of portfolio
Commodore Capital LP New York, NY

3.2M
Shares

$151 Million
16.98% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

2.75M
Shares

$130 Million
3.41% of portfolio
Federated Hermes, Inc. Pittsburgh, PA

2.4M
Shares

$113 Million
0.34% of portfolio
Samlyn Capital, LLC New York, NY

2.32M
Shares

$110 Million
2.45% of portfolio

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.16B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account